Aetna Prior Authorization Automation: Optimize Your Workflow

Aetna Prior Authorization Submission Channels

Aetna leverages multiple channels for prior authorization submissions, varying by benefit category. Klivira's platform integrates with these diverse pathways to ensure compliant and efficient request routing. For medical-benefit precertifications, Aetna primarily utilizes the Availity provider portal for commercial and Medicare Advantage plans (src: aetna-precert, availity-aetna), alongside support for X12 278 transactions via clearinghouses for specific procedure categories (src: aetna-precert).

Key Aetna Submission Pathways

• **Medical Benefit:** Predominantly via the Availity provider portal and X12 278 for eligible procedure codes (src: aetna-precert, availity-aetna).
• **Pharmacy Benefit:** Administered through CVS Caremark (src: cvs-caremark), with submissions routing through ePA partners such as CoverMyMeds and Surescripts for retail pharmacy PA, and CVS Caremark's direct portal for mail-order scenarios.
• **Specialty Drugs (Medical Benefit):** Managed under specific specialty-pharmacy-management workflows, distinct from standard medical PA.
• **Inpatient Admissions:** Concurrent review intake procedures are detailed on Aetna's precertification page, with notification windows varying by line of business and state regulations (src: aetna-precert).

Aetna Utilization Management Policy and Criteria

Aetna's medical necessity criteria are publicly available as Clinical Policy Bulletins (CPBs) (src: aetna-cpb). These CPBs are versioned, dated, and serve as the canonical identifier for Aetna's utilization management policies. Each CPB specifies whether the criteria are internally developed or rely on external sources like MCG or NCCN compendia, providing transparency into the decision-making framework.

Prior Authorization Turnaround Times and Regulatory Impact

Aetna's prior authorization turnaround times are influenced by state-mandated minimums, payer-published service-level targets (src: aetna-precert), and accreditation standards. Commercial plans adhere to NCQA Utilization Management accreditation norms (src: ncqa-um-standards). Additionally, Aetna's Medicare Advantage, Medicaid managed-care, CHIP, and QHP lines of business are impacted by the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F), which mandates 72-hour decisions for standard and 24-hour for expedited PA requests on a phased compliance timeline (src: cms-0057-f). It is important to note that Aetna's commercial line of business is not directly impacted by CMS-0057-F.

Electronic Prior Authorization (ePA) and FHIR Initiatives

Klivira supports electronic prior authorization for Aetna, particularly for pharmacy benefits through established ePA partners like CoverMyMeds and Surescripts. While Aetna participates in HL7 connectathons focusing on standards like CRD and DTR, its production conformance with the Da Vinci Prior Authorization Support (PAS) Implementation Guide has not been independently verified at this time (src: davinci-pas-ig). Klivira continuously monitors Aetna's evolving ePA capabilities to ensure seamless integration for our clients.

Managing Aetna Prior Authorization Denials and Appeals

Aetna communicates denial reasons via X12 835/277 transactions for electronic submissions and through Availity portal status updates, utilizing standard CARC and RARC vocabularies. Common denial categories include medical necessity, insufficient documentation, step therapy non-compliance, site-of-service mismatches, and off-label use without compendium support. Klivira helps track these reasons, informing appeal strategies. Aetna's provider manual outlines the appeal pathway, which typically includes reconsideration, peer-to-peer review, and formal appeals, with expedited options for urgent cases.